Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.
Bibliographical notePublisher Copyright:
© 2014 by John Wiley & Sons, Ltd. All rights reserved.
- Kidney cancer
- Radiofrequency ablation
- Renal cell carcinoma